Cue Health receives first-ever de novo authorization for at-home COVID test
Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID test dubbed Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects genetic material from the SARS-CoV-2 virus and…
Continue Reading